Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Journal of Periodontology
|
December 4, 2018
Effects of statins on multispecies oral biofilm identify simvastatin as a drug candidate targeting Porphyromonas gingivalis
Marta Kamińska, Ardita Aliko, Annelie Hellvard, et al.
Scientific Reports
|
August 12, 2016
Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis
Annelie Hellvard, Lutz Zeitlmann, Ulrich Heiser, et al.
Journal of Innate Immunity
|
November 28, 2015
Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis
Małgorzata Benedyk, Piotr Mateusz Mydel, Nicolas Delaleu, et al.
Scientific Reports
|
September 22, 2018
Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape
Ardita Aliko, Marta Kamińska, Brith Bergum, et al.
Annals of the Rheumatic Diseases
|
September 10, 2015
Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity
Brith Bergum, Catalin Koro, Nicolas Delaleu, et al.
American Journal of Physiology. Renal Physiology
|
March 7, 2019
Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms
Even Koch, Kenneth Finne, Øystein Eikrem, et al.
Thrombosis and Haemostasis
|
April 7, 2017
Impact of fibrinogen carbamylation on fibrin clot formation and stability
Veronika Binder, Brith Bergum, Stéphane Jaisson, et al.
Biomedicines
|
January 21, 2023
Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target
Øystein Eikrem, Bjørnar Lillefosse, Nicolas Delaleu, et al.
Kidney International
|
July 7, 2023
Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing
Nicolas Delaleu, Hans-Peter Marti, Philipp Strauss, et al.
Innate Immunity
|
February 17, 2016
Carbamylated LL-37 as a modulator of the immune response
Catalin Koro, Annelie Hellvard, Nicolas Delaleu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Journal of Periodontology
|
December 4, 2018
Effects of statins on multispecies oral biofilm identify simvastatin as a drug candidate targeting Porphyromonas gingivalis
Marta Kamińska, Ardita Aliko, Annelie Hellvard, et al.
Scientific Reports
|
August 12, 2016
Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis
Annelie Hellvard, Lutz Zeitlmann, Ulrich Heiser, et al.
Journal of Innate Immunity
|
November 28, 2015
Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis
Małgorzata Benedyk, Piotr Mateusz Mydel, Nicolas Delaleu, et al.
Scientific Reports
|
September 22, 2018
Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape
Ardita Aliko, Marta Kamińska, Brith Bergum, et al.
Annals of the Rheumatic Diseases
|
September 10, 2015
Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity
Brith Bergum, Catalin Koro, Nicolas Delaleu, et al.
American Journal of Physiology. Renal Physiology
|
March 7, 2019
Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms
Even Koch, Kenneth Finne, Øystein Eikrem, et al.
Thrombosis and Haemostasis
|
April 7, 2017
Impact of fibrinogen carbamylation on fibrin clot formation and stability
Veronika Binder, Brith Bergum, Stéphane Jaisson, et al.
Biomedicines
|
January 21, 2023
Network-Based Assessment of Minimal Change Disease Identifies Glomerular Response to IL-7 and IL-12 Pathways Activation as Innovative Treatment Target
Øystein Eikrem, Bjørnar Lillefosse, Nicolas Delaleu, et al.
Kidney International
|
July 7, 2023
Systems analyses of the Fabry kidney transcriptome and its response to enzyme replacement therapy identified and cross-validated enzyme replacement therapy-resistant targets amenable to drug repurposing
Nicolas Delaleu, Hans-Peter Marti, Philipp Strauss, et al.
Innate Immunity
|
February 17, 2016
Carbamylated LL-37 as a modulator of the immune response
Catalin Koro, Annelie Hellvard, Nicolas Delaleu, et al.
Page
of 4